电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

SETD2 抗体

SETD2 适用: 小鼠 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN7075582
发货至: 中国
  • 抗原 See all SETD2 抗体
    SETD2 (SET Domain Containing 2 (SETD2))
    适用
    • 28
    • 7
    • 5
    • 2
    • 2
    • 2
    小鼠
    宿主
    • 24
    • 3
    • 1
    克隆类型
    • 25
    • 3
    多克隆
    标记
    • 16
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This SETD2 antibody is un-conjugated
    应用范围
    • 12
    • 12
    • 11
    • 10
    • 6
    • 4
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
    纯化方法
    Affinity purification
    免疫原
    Recombinant protein corresponding to Mouse KMT3A / HYPB / HIF-1
    Top Product
    Discover our top product SETD2 Primary Antibody
  • 应用备注
    WB (M) 1:300-1:500, IHC/IF (M) 1:1800-1:3600
    限制
    仅限研究用
  • 状态
    Liquid
    缓冲液
    PBS, pH 7.4, 0.02 % sodium azide
    储存液
    Sodium azide
    注意事项
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    -20 °C
  • 抗原
    SETD2 (SET Domain Containing 2 (SETD2))
    别名
    KMT3A / HYPB / HIF-1 (SETD2 产品)
    别名
    Kif9 antibody, HBP231 antibody, HIF-1 antibody, HIP-1 antibody, HYPB antibody, KMT3A antibody, SET2 antibody, p231HBP antibody, SET domain containing 2 antibody, Setd2 antibody, SETD2 antibody
    背景
    SETD2, also named as HIF1, HYPB, KIAA1732, KMT3A, SET2, p231HBP, hSET2 and HIP-1, belongs to the histone-lysine methyltransferase family and SET2 subfamily. SETD2 probably plays a role in chromatin structure modulation during elongation via its interaction with hyperphosphorylated POLR2A. It binds DNA at promoters. SETD2 may also act as a transcription activator that binds to promoters. It is a potential tumour suppressor gene in breast cancer. This antibody is specific to SETD2.
    分子量
    286 kDa
    基因ID
    235626
    UniProt
    E9Q5F9
    途径
    Tube Formation
You are here: